|
Resverlogix poster from AHA 2016
|
1
|
Resverlogix Corp.
|
Nov 18, 2016 02:27PM
|
|
Resverlogix poster at American Diabetes Association meeting on Sunday June 7
|
6
|
Resverlogix Corp.
|
Jun 05, 2015 08:23PM
|
|
Resverlogix Plans COVID-19 Clinical Trial Program Launch
|
6
|
Resverlogix Corp.
|
Jun 01, 2020 09:38AM
|
|
Resverlogix on schedule to present at BIO CEO Tuesday 2/13
|
1
|
Resverlogix Corp.
|
Feb 06, 2018 04:58PM
|
|
Resverlogix October 2018 events
|
7
|
Resverlogix Corp.
|
Oct 08, 2018 05:35PM
|
|
Resverlogix NYAS Symposium notes
|
12
|
Resverlogix Corp.
|
Apr 29, 2016 12:50PM
|
|
Resverlogix needs to host another R&D Day for Investors and Analysts
|
4
|
Resverlogix Corp.
|
Jul 03, 2018 10:24AM
|
|
Resverlogix June 30th Special Meeting Information Circular
|
3
|
Resverlogix Corp.
|
Jun 09, 2015 11:41AM
|
|
Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 08:18AM
|
|
Resverlogix Intends to Pursue U.S. Listing
|
4
|
Resverlogix Corp.
|
Jul 31, 2018 06:21PM
|
|
Resverlogix in the next 6 weeks
|
1
|
Resverlogix Corp.
|
Aug 19, 2015 02:46PM
|
|
Resverlogix in the next 2.5 weeks (plus bonus October event)
|
4
|
Resverlogix Corp.
|
Aug 28, 2016 10:38PM
|
|
Resverlogix H2 2018 events
|
7
|
Resverlogix Corp.
|
Jul 18, 2018 12:14PM
|
|
Resverlogix Files Notice of Annual and Special Meeting of Shareholders
|
1
|
Resverlogix Corp.
|
Nov 21, 2020 08:46AM
|
|
Resverlogix featured in Bio Business Magazine
|
2
|
Resverlogix Corp.
|
May 24, 2016 03:23PM
|
|
RESVERLOGIX EXCEEDS FULL ENROLLMENT FOR THE PIVOTAL PHASE 3 BETONMACE CLINICAL TRIAL
|
|
Resverlogix Corp.
|
Mar 19, 2018 07:39AM
|
|
Resverlogix Data in Brief Article
|
2
|
Resverlogix Corp.
|
Aug 30, 2016 10:46AM
|
|
Resverlogix Corporate Update Slide Deck
|
1
|
Resverlogix Corp.
|
Dec 15, 2016 11:23AM
|
|
Resverlogix Corporate Update 4/23/2019
|
5
|
Resverlogix Corp.
|
Apr 23, 2019 10:51PM
|
|
Resverlogix Confirms Significant Corporate Advancement Establishing Apabetalone as Potential Blockbuster Combo Drug in High-risk Diabetics with CVD
|
2
|
Resverlogix Corp.
|
Jan 13, 2020 08:29AM
|
